Translational Research Cancer Cente

Nonprofit profile at a glance

EIN
831794049
IRS 990 coverage
2024–2024
Forms available
Form 990 2024, Form 990-EZ 2023, Form 990-N 2021
Location
Pittsburgh, PA, USA
Rating
69
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Health

Official website

Reported finances

Revenue
$239,968
Expenses
$121,759
Assets
$213,822
Liabilities
$3,380

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

27 people listed

Executive titles in this filing

  • Daniel J Powell Jr (Past President)
  • Jonathan Bramson (President)
  • Wei-Zen Wei (Past President)
  • Pawel Kalinski (Vice President)

People named in this filing

  • Stephen Haley (Director)
  • Kristin Anderson (Director)
  • Sonikpreet Aulakh (Director)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Dissemination of information regarding the prevention, treatment, and cure of cancer, integrating cancer biology and tumor immunology. Promoting research, clinical collaborations, enhanced partnerships with industry, and training of the next generation of scientists.

What it reported doing in 2024

The TRCCC is composed of Cancer Centers, or Academic Institutions with a major focus on cancer research, within an easily accessible distance to the yearly meeting site that advances the dissemination of research and new clinical trials towards the prevention, treatment and cure of cancer, with an emphasis on the study of Immuno-Oncology, immunotherapy and other biological therapies of cancer. Each member institution may choose up to two faculty members to provide their current research in platform presentations, and to have their trainees present short talks and/or posters, at the yearly meeting. Each member institution also can have their Center participate in any clinical trials that are developed at TRC3 centers and other types of inter-institutional scientific collaborations and training opportunities, such as joint NIH training grants, NCI SPORES and P01s.

Operating model

Revenue model
Earned-program. 100% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - The filed numbers largely add up and most voting board members are independent. A relatively small share of available resources goes toward mission work and some filing-based governance responses are negative or unanswered.

Rating breakdown

  • Financial Efficiency: 54
  • Transparency & Controls: 85
  • Accountability: 76
  • Sustainability: 72
  • Growth: 60

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 44.7%; rating input score 45
  • Program expense ratio: 88%; rating input score 88
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 90.9%; rating input score 91; 13th percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
  • Governance controls: 3 of 7 controls in place; rating input score 43
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Fail
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 49.3%; rating input score 91; 91st percentile among comparable filings
  • Total-asset coverage ratio: 1.76; rating input score 56; 56th percentile among comparable filings
  • Liabilities to assets ratio: 0.02; rating input score 42; 42nd percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 69; 69th percentile among comparable filings

Growth

  • Program expense growth: Limited
  • Revenue growth: 48.2% per year; rating input score 100; 97th percentile among comparable filings
  • Asset growth: 41.5% per year; rating input score 100; 95th percentile among comparable filings

Details

  • Where the money goes: 44.7% of revenue deployed · 88% of spending went to programs
  • Governance: 27 of 27 board members independent · 3 of 7 filing controls reported
  • Programs: 2 filed program accomplishments · $107K in reported program spending
  • Leadership: top reported pay $0 · 27 people listed
  • Consistency: 17 of 18 current checks pass · 1 finding to review
  • Schedules: 4 filed schedules · includes major donors
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Moderate — Financial Efficiency: Mission deployment rate scored 45/100.
  • Moderate — Accountability: Governance controls: 4 of 7 not reported.
  • Moderate — Transparency & Controls: Schedule A contributions reconciliation did not reconcile in the filed values.
  • Review — Sustainability: Total-asset coverage ratio scored 56/100.
  • Moderate — Sustainability: Liabilities to assets ratio scored 42/100.